ADAMTS-3 (Recombinant)
- Expression system
- HEK293
- Cat. #
- REC-ADAMTS3
In stock
- SKU
- REC-ADAMTS3
Target Overview
ADAMTS-3 (UniProt O15072; gene ADAMTS3) is a secreted zinc-dependent metalloproteinase belonging to the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) family. Its primary defined enzymatic function is cleavage of the N-propeptides of type II procollagen prior to fibril assembly; it does not act on type I or type III collagens under established assay conditions, making it a selective reagent for type II collagen processing studies. The full-length human sequence spans 1,205 amino acids and encodes the canonical domain architecture of the ADAMTS family: a prodomain, metalloproteinase domain, disintegrin-like domain, thrombospondin type 1 motif repeats, and a cysteine-rich spacer region. This recombinant form is produced in HEK293 mammalian cells, an expression system that supports the glycosylation and disulfide bonding required for correct folding of the metalloproteinase and thrombospondin domains. Mammalian expression is particularly relevant for ADAMTS family members, where post-translational modifications influence substrate recognition and enzyme activity. Researchers use this recombinant protein in several experimental contexts: as an active enzyme source in procollagen II N-propeptide cleavage assays; as a target for small-molecule inhibitor IC50 determination; as a positive control antigen in Western blot or ELISA assay development; and as a calibration standard for quantitative immunoassays. Laboratories developing or validating antibodies against ADAMTS-3 can pair this recombinant directly with the matched Triple Point Biologics antibody (catalog SKU: RP-ADAMTS3) to confirm antigen recognition under denaturing and native conditions. The secreted, processed form produced in HEK293 cells is well-suited to solution-phase binding and activity measurements without renaturation steps.
Background
Applications
- Procollagen II N-propeptide cleavage activity assay using type II procollagen substrate
- Small-molecule inhibitor IC50 determination in solution-phase metalloproteinase assay formats
- Antibody validation positive control antigen for Western blot (paired with TPB SKU RP-ADAMTS3)
- ELISA calibration standard for quantitative measurement of ADAMTS-3 in conditioned media or tissue lysates
- Substrate selectivity profiling comparing ADAMTS-3 activity against type I, II, and III procollagen substrates
- Biophysical binding studies (SPR or BLI) characterising ADAMTS-3 interaction with ECM components or inhibitor candidates
- Recombinant antigen for immunisation or antibody specificity screening in ADAMTS family cross-reactivity panels
References
- Altuntaş C et al. Hypoxia reprograms VEGF signaling to differentially control ADAMTS2 and ADAMTS3 expression in endothelial cells. Tissue Cell. 2026. doi:10.1016/j.tice.2026.103636. PMID: 42224870
- Schlaudraff J et al. Spatiotemporal patterns of gene expression changes in the mouse dentate gyrus following entorhinal denervation. Front Mol Neurosci. 2026. doi:10.3389/fnmol.2026.1758390. PMID: 42239799
- Li F et al. FTO-mediated m(6)A demethylation of CRTC1 coordinates with p300 and EGR2 to promote alveolar ECM degradation in acute respiratory distress syndrome. Int Immunopharmacol. 2026. doi:10.1016/j.intimp.2025.115917. PMID: 41273842
- Melhorn H et al. Incidentally identified aortic dissection in a Great Pyrenees dog. J Vet Cardiol. 2025. doi:10.1016/j.jvc.2025.09.007. PMID: 41172595
- Chauhan B et al. Homozygous Nonsense Variant in the GJA4 Gene Associated With Increased Fetal Nuchal Fold Thickness and Abnormal Fetal Ductus Venosus Termination: A Case Report. Cureus. 2025. doi:10.7759/cureus.97033. PMID: 41416265
Additional Specifications
| Storage Buffer | 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM CaCl₂, 10% glycerol |
|---|---|
| Endotoxin Level | <0.1 EU/µg by LAL |
| Purity (%) | >90% by SDS-PAGE |
| Expression System | HEK293 |
| Subcellular Localization | Secreted; Extracellular matrix |
Frequently Asked Questions
What is the expected molecular weight of recombinant ADAMTS-3 on SDS-PAGE or Western blot?
The full-length human ADAMTS-3 sequence (1,205 aa, UniProt O15072) predicts an unmodified MW of ~133 kDa. Because this recombinant is produced in HEK293 cells, N-linked glycosylation adds appreciable mass; expect a diffuse band or doublet migrating at approximately 150–170 kDa under reducing SDS-PAGE conditions. Band sharpness improves with PNGase F treatment if you need to confirm the peptide backbone. The prodomain may be partially or fully processed, so a secondary band near 100–110 kDa (mature metalloproteinase-containing fragment) is occasionally observed at higher loads.
Does recombinant ADAMTS-3 cleave type I or type III procollagen, or is it specific to type II?
Under established assay conditions, ADAMTS-3 is selective for the N-propeptide of type II procollagen (pNII collagen substrate) and does not show appreciable activity toward type I or type III procollagen N-propeptides. This substrate selectivity makes it the preferred reagent when you need to isolate type II collagen processing from the broader ADAMTS family activity present in complex lysates. If your experimental model involves type I or III collagen turnover, ADAMTS-2 or ADAMTS-14 are more appropriate choices.
What substrate should I use for an ADAMTS-3 activity assay in vitro?
The best-characterized substrate for ADAMTS-3 activity assays is recombinant type II procollagen N-propeptide (pNII). Fluorogenic FRET peptides spanning the ADAMTS-3 cleavage site in the type II procollagen N-propeptide can also be used to obtain continuous kinetic readouts. Assay buffer should be 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM CaCl₂ — matching the storage buffer to minimize dilution-related activity loss. Zinc chelators (EDTA, 1,10-phenanthroline) and broad-spectrum hydroxamate inhibitors (e.g., GM6001) serve as reliable negative controls to confirm zinc-dependence of the signal.
What starting concentration and buffer conditions should I use when setting up an ADAMTS-3 enzyme activity experiment?
A practical starting point is 1–10 nM recombinant ADAMTS-3 in 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM CaCl₂. The enzyme is supplied and stable in this buffer, so diluting directly into matched assay buffer avoids pH or ionic-strength shifts that can denature the metalloproteinase domain. Pre-warm the diluted enzyme at 37 °C for 10 minutes before adding substrate. BSA (0.01–0.1%) can reduce non-specific surface adsorption at low enzyme concentrations. Titrate enzyme concentration against a fixed substrate to confirm you are working in the linear range before running inhibitor or IC₅₀ experiments.
Can I use ADAMTS-3 (Recombinant) as a positive control for Western blot with the matched TPB antibody RP-ADAMTS3?
Yes — this is a primary intended use case. REC-ADAMTS3 and the matched rabbit polyclonal RP-ADAMTS3 (/anti-adamts-3-rabbit-polyclonal-antibody) are validated together for Western blot. Load 50–200 ng of recombinant ADAMTS-3 per lane alongside your experimental samples. The antibody should detect the glycosylated band at ~150–170 kDa. Because the recombinant and antibody originate from the same platform, this pairing is also suitable for confirming antibody lot-to-lot consistency and for establishing that your antigen retrieval or transfer conditions are working before attributing absence of signal to biology.
How much recombinant ADAMTS-3 should I load for a Western blot positive control lane?
Load 50–200 ng in a single lane as your positive control. At 100 ng, a band at ~150–170 kDa is reliably detected with RP-ADAMTS3 at a 1:1,000–1:2,000 primary antibody dilution using standard ECL detection. If you are using a fluorescent secondary system, 50 ng is often sufficient. Avoid loading more than 500 ng per lane — excess glycoprotein can produce smearing that obscures the migration position you intend to benchmark. Run the positive control lane adjacent to your highest-expression sample lane to make direct size comparisons on the same gel straightforward.
How should I store and handle ADAMTS-3 (Recombinant) to maintain enzyme activity long-term?
Store at −20 °C in the supplied single-use aliquots (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol, 5 mM CaCl₂). The 10% glycerol provides cryoprotection; do not dilute it out of the storage aliquot until just before use. Repeated freeze-thaw cycles progressively reduce metalloproteinase activity — even two cycles can cause measurable loss. Once thawed, keep on ice and use within 4–6 hours. If you anticipate multiple uses from one vial, pre-aliquot into single-use volumes upon first receipt. Avoid plastic tubes with high protein-binding capacity; low-bind microcentrifuge tubes are recommended at concentrations below 50 µg/mL.
Is ADAMTS-3 (Recombinant) suitable for antibody validation experiments, and how does it pair with RP-ADAMTS3?
REC-ADAMTS3 is well-suited for antigen-specific antibody validation. Run a dilution series (25, 50, 100, 200 ng) alongside negative lysate (e.g., ADAMTS3-knockout cell lysate or a cell line with no detectable endogenous expression) and probe with RP-ADAMTS3. A single concentration-dependent band confirms specificity; additional bands in the recombinant lane but not the lysate lane are likely glycoform variants rather than off-target reactivity. This approach directly satisfies the recombinant-protein positive control requirement outlined in antibody validation guidelines (e.g., those from the International Working Group for Antibody Validation).
Validation imagery coming soon
Western blot validation figures for REC-ADAMTS3 will be published here as they are produced in-house.
If you would like to see existing validation data for this antibody before publication, request a sample copy.